Predicted to enable RNA binding activity and protein C-terminus binding activity. Predicted to be located in cell leading edge and cytoplasmic ribonucleoprotein granule. Predicted to be part of catalytic step 2 spliceosome. Predicted to be active in cytoplasmic stress granule; cytosol; and nucleus. Is expressed in several structures, including alimentary system; brain; nose; urinary system; and vibrissa. Orthologous to human PABPC1 (poly(A) binding protein cytoplasmic 1). [provided by Alliance of Genome Resources, Apr 2022]